Neurelis, Inc., based in San Diego, CA, is an innovation-driven neuroscience company providing a highly differentiated approach to target unmet medical needs in managing epilepsy. Neurelis’ first commercial product was approved on January 10, 2020. Visit www.Neurelis.com to learn more.
Neurelis is focused on therapies that empower patients, care partners, and healthcare providers. Their unique approach leverages both internal and external innovation and technology platforms to unlock opportunities for better patient care.
For more information on Neurelis, please visit www.Neurelis.com.